These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25016653)
41. Antioxidant Activities and Reduced Amyloid-β Toxicity of 7-Hydroxycalamenene Isolated from the Essential Oil of Zelkova serrata Heartwood. Yen PL; Cheng SS; Wei CC; Lina HY; Liao VH; Chang ST Nat Prod Commun; 2016 Sep; 11(9):1357-1362. PubMed ID: 30807042 [TBL] [Abstract][Full Text] [Related]
42. Resveratrol-loaded nanocarriers: formulation, optimization, characterization and in vitro toxicity on cochlear cells. Musazzi UM; Youm I; Murowchick JB; Ezoulin MJ; Youan BB Colloids Surf B Biointerfaces; 2014 Jun; 118():234-42. PubMed ID: 24816150 [TBL] [Abstract][Full Text] [Related]
43. Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Stojanović S; Sprinz H; Brede O Arch Biochem Biophys; 2001 Jul; 391(1):79-89. PubMed ID: 11414688 [TBL] [Abstract][Full Text] [Related]
44. Resveratrol and Amyloid-Beta: Mechanistic Insights. Jia Y; Wang N; Liu X Nutrients; 2017 Oct; 9(10):. PubMed ID: 29036903 [TBL] [Abstract][Full Text] [Related]
45. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197 [TBL] [Abstract][Full Text] [Related]
46. Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans. Gruber J; Tang SY; Halliwell B Ann N Y Acad Sci; 2007 Apr; 1100():530-42. PubMed ID: 17460219 [TBL] [Abstract][Full Text] [Related]
47. Antioxidant Peptides from Yu X; Su Q; Shen T; Chen Q; Wang Y; Jia W Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 32993031 [TBL] [Abstract][Full Text] [Related]
48. Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol. Caddeo C; Pucci L; Gabriele M; Carbone C; Fernàndez-Busquets X; Valenti D; Pons R; Vassallo A; Fadda AM; Manconi M Int J Pharm; 2018 Mar; 538(1-2):40-47. PubMed ID: 29294324 [TBL] [Abstract][Full Text] [Related]
49. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease. Yang L; Wang Y; Li Z; Wu X; Mei J; Zheng G Carbohydr Polym; 2023 Jun; 310():120714. PubMed ID: 36925241 [TBL] [Abstract][Full Text] [Related]
50. Carlina acaulis Exhibits Antioxidant Activity and Counteracts Aβ Toxicity in Caenorhabditis elegans. Link P; Roth K; Sporer F; Wink M Molecules; 2016 Jul; 21(7):. PubMed ID: 27384550 [TBL] [Abstract][Full Text] [Related]
51. Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease. Lin YF; Lee YH; Hsu YH; Chen YJ; Lin YF; Cheng FY; Chiu HW Nanomedicine (Lond); 2017 Nov; 12(22):2741-2756. PubMed ID: 28884615 [TBL] [Abstract][Full Text] [Related]
52. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity. Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056 [TBL] [Abstract][Full Text] [Related]
53. Synergistic anti-glioma effect of a coloaded nano-drug delivery system. Xu H; Jia F; Singh PK; Ruan S; Zhang H; Li X Int J Nanomedicine; 2017; 12():29-40. PubMed ID: 28031711 [TBL] [Abstract][Full Text] [Related]
55. Resveratrol reduces lipid peroxidation and increases sirtuin 1 expression in adult animals programmed by neonatal protein restriction. Franco JG; de Moura EG; Koury JC; Trotta PA; Cordeiro A; Souza LL; Almeida NA; Lima Nda S; Pazos-Moura CC; Lisboa PC; Passos MC J Endocrinol; 2010 Dec; 207(3):319-28. PubMed ID: 20870710 [TBL] [Abstract][Full Text] [Related]
56. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress. Pangeni R; Sharma S; Mustafa G; Ali J; Baboota S Nanotechnology; 2014 Dec; 25(48):485102. PubMed ID: 25392203 [TBL] [Abstract][Full Text] [Related]
57. Effect of the Biphenyl Neolignan Honokiol on Aβ Kantham S; Chan S; McColl G; Miles JA; Veliyath SK; Deora GS; Dighe SN; Khabbazi S; Parat MO; Ross BP ACS Chem Neurosci; 2017 Sep; 8(9):1901-1912. PubMed ID: 28650631 [TBL] [Abstract][Full Text] [Related]
58. Preparation, Characterization, and In Vitro/In Vivo Evaluation of 3-O-β-D-Galactosylated Resveratrol-Loaded Polydopamine Nanoparticles. Wang B; Shan X; Lv S; Zha L; Zhang C; Dong Q; Chen W AAPS PharmSciTech; 2021 Aug; 22(7):220. PubMed ID: 34405290 [TBL] [Abstract][Full Text] [Related]
59. Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies. Rigon RB; Fachinetti N; Severino P; Santana MH; Chorilli M Molecules; 2016 Jan; 21(1):E116. PubMed ID: 26805794 [TBL] [Abstract][Full Text] [Related]
60. Resveratrol nanoformulations: challenges and opportunities. Summerlin N; Soo E; Thakur S; Qu Z; Jambhrunkar S; Popat A Int J Pharm; 2015 Feb; 479(2):282-90. PubMed ID: 25572692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]